Literature DB >> 36105332

Orexin Receptor Agonists as Possible Treatment for Narcolepsy and Idiopathic Hypersomnia.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2022        PMID： 36105332      PMCID： PMC9465891          DOI： 10.1021/acsmedchemlett.2c00358

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  4 in total

Review 1.  Orexin research: patent news from 2016.

Authors:  Christoph Boss; Catherine Roch
Journal:  Expert Opin Ther Pat       Date:  2017-06-28       Impact factor: 6.674

Review 2.  Orexin receptors: Targets and applications.

Authors:  Subhiksha Subramanian; Mirunalini Ravichandran
Journal:  Fundam Clin Pharmacol       Date:  2021-09-13       Impact factor: 2.748

Review 3.  Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders. Rationale for development and current status.

Authors:  Michihiro Mieda; Takeshi Sakurai
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

4.  Discovery of the First Selective, Nonpeptidic Orexin 2 Receptor Agonists.

Authors:  Alexander Heifetz; Mike J Bodkin; Philip C Biggin
Journal:  J Med Chem       Date:  2015-09-16       Impact factor: 8.039
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.